07:00 , Mar 11, 2013 |  BC Week In Review  |  Company News

CoCo Therapeutics neurology news

CoCo Therapeutics debuted earlier this month with undisclosed funding from Advent Venture Partners to develop retinoic acid receptor alpha (RARA) agonists to treat Alzheimer's disease. Founding Chairman Raj Parekh, general partner at Advent, said CoCo...
07:00 , Mar 11, 2013 |  BioCentury  |  Finance

Advent warms CoCo

Advent warms CoCo On the heels of data published last month from the lab of Jonathan Corcoran, Advent Venture Partners launched CoCo Therapeutics Ltd. to develop his retinoic acid receptor alpha (RARA) agonists to treat...
01:54 , Mar 9, 2013 |  BC Extra  |  Company News

CoCo debuts to develop AD therapeutics

CoCo Therapeutics Ltd. (Oxford, U.K) debuted with undisclosed funding from Advent Venture Partners to develop retinoic acid receptor alpha (RARA) agonists to treat Alzheimer's disease. Founding Chairman Raj Parekh, general partner at Advent, said CoCo...